Laurelton Heart Specialists — Rosedale, New York

Laurelton Heart Specialists is a clinical research site located in Rosedale, New York, United States 11422.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Laurelton Heart Specialists has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Amyloid Cardiomyopathy, Transthyretin-Related, Heart Failure, Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM).

Sponsors: Eidos Therapeutics, a BridgeBio company, Bayer, Ionis Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Laurelton Heart Specialists?

Laurelton Heart Specialists has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Laurelton Heart Specialists conducted?

Laurelton Heart Specialists has 4 clinical trials on record, with 3 currently active. Their work covers Amyloid Cardiomyopathy, Transthyretin-Related, Heart Failure, Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM).

Is Laurelton Heart Specialists accredited by Crixeo Health?

Yes — Laurelton Heart Specialists holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Laurelton Heart Specialists?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.